Therefore, suppression of hepatic Rspo3 is associated with obesity-induced insulin resistance, systemically, as well as diabetes and changes in body compositions including the distributions of adipose tissue and skeletal muscle. This evidence concerns the gene RSPO3 and Insulin resistance.